Ginkgo Bioworks Holdings (DNA) Profit After Tax Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -3.37% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 34.46% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -64.34% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -102.81% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 96.48% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 4.94% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 8.58% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 99.80% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.94% |
| Mar 31, 2026 | 8.48% |
| Dec 31, 2025 | 26.32% |
| Sep 30, 2025 | -43.18% |
| Jun 30, 2025 | 72.26% |
| Mar 31, 2025 | 46.16% |
| Dec 31, 2024 | 48.16% |
| Sep 30, 2024 | 81.48% |
| Jun 30, 2024 | -25.41% |
| Mar 31, 2024 | 17.57% |
| Dec 31, 2023 | -26.00% |
| Sep 30, 2023 | 54.73% |
| Jun 30, 2023 | 74.15% |
| Mar 31, 2023 | 65.41% |
| Dec 31, 2022 | 89.56% |
| Sep 30, 2022 | -556.75% |
| Jun 30, 2022 | -1,131.22% |
| Mar 31, 2022 | -692.47% |
| Dec 31, 2021 | -3,362.81% |
| Sep 30, 2021 | -291.97% |